Liu, Shun-Jin, Liu, Xiao-Yu, Li, Jing-Hui, Guo, Jing, Li, Fan, Gui, Yang, Li, Xiu-Hua, Yang, Li, Wu, Chun-Yun, Yuan, Yun, and Li, Juan-Juan
Abstract Microglia activation and its mediated production of proinflammatory mediators play important roles in different neurodegenerative diseases; hence, modulation of microglia activation has been considered a potential therapeutic strategy to ameliorate neurodegeneration. This study was aimed to determine whether Gastrodin, a common herbal agent known to possess neuroprotective property, can attenuate production of proinflammatory mediators in activated microglia through the renin-angiotensin system (RAS) and Sirtuin3 (SIRT3). Expression of various members of the RAS including ACE, AT 1 , AT 2, and SIRT3 in activated microglia was assessed by immunofluorescence and Western blot in hypoxic-ischemia brain damage (HIBD) in postnatal rats, and in BV-2 microglia in vitro challenged with lipopolysaccharide (LPS) with or without Gastrodin treatment. Expression of NOX-2, a subunit of NADPH oxidase, and proinflammatory mediators including iNOS and TNF-α, was also evaluated. The present results showed that expression of ACE, AT 1 , NOX-2, iNOS and TNF-α was markedly increased in activated microglia in the corpus callosum of HIBD rats, and in LPS stimulated BV-2 microglia. Remarkably, the expression was markedly attenuated following Gastrodin treatment. Conversely, Gastrodin enhanced AT 2 and SIRT3 protein expression. In BV-2 microglia treated with Azilsartan, a specific inhibitor of AT 1 (AT 1 I group), NOX-2 expression was decreased whereas that of SIRT3 in LPS + AT 1 I and LPS + Gastrodin group was increased when compared with the controls. In LPS + AT 1 I + Gastrodin group, SIRT3 expression was further augmented. More importantly, Gastrodin effectively reduced caspase 3 protein expression level in the HIBD rats coupled with a significant decrease in caspase 3 positive cells. We conclude that Gastrodin can exert its protective effects against the hypoxic-ischemia brain damage in the present experimental HIBD model. It is suggested that this is mainly through suppression of expression of RAS (except for AT 2 and SIRT3) and proinflammatory mediators e.g. TNF-α in activated microglia. Highlights • Gastrodin suppresses renin-angiotensin system in activated microglia. • Gastrodin decreases proinflammatory mediators. • Gastrodin enhances SIRT3 expression in activated microglia. • Gastrodin acts through AT 1 receptor. [ABSTRACT FROM AUTHOR]